Teva Pharmaceutical Industries' Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. Management's cautious 2025 guidance sets a low bar, likely to be ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

I've been on more than a dozen cruise ships in my lifetime, which has given me plenty of experience in determining what to ...

There's nothing set in stone about the iPhone Flip right now, but the volume of rumors we've heard make it clear that it's something Apple wants to make. But Apple seems to be quietly working on a ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

1 Day TEVA -0.62% DJIA -0.75% S&P 500 -0.50% Health Care/Life Sciences 0.29% ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

After hours: January 31 at 7:58:37 p.m. EST ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

"Flip smartphones are popular for their blend of style, functionality, and nostalgia. Their compact, foldable design saves space, making them convenient for pocket storage. When opened, they offer ...

A film that more than doubles the investment by an additional 50% Flop: A film that loses 50% or more of its investment Losing: A film that does not recover the investment but loses less than 50% ...